Order Article Reprints

He Q, Bu F, Zhang H, Wang Q, Tang Z, Yuan J, Lin H-S, Xiang X. Investigation of the Impact of CYP3A5 Polymorphism on Drug–Drug Interaction between Tacrolimus and Schisantherin A/Schisandrin A Based on Physiologically-Based Pharmacokinetic Modeling. Pharmaceuticals. 2021; 14(3):198. https://doi.org/10.3390/ph14030198

He, Qingfeng, Fengjiao Bu, Hongyan Zhang, Qizhen Wang, Zhijia Tang, Jing Yuan, Hai-Shu Lin, and Xiaoqiang Xiang. 2021. "Investigation of the Impact of CYP3A5 Polymorphism on Drug–Drug Interaction between Tacrolimus and Schisantherin A/Schisandrin A Based on Physiologically-Based Pharmacokinetic Modeling" Pharmaceuticals 14, no. 3: 198. https://doi.org/10.3390/ph14030198

He, Q., Bu, F., Zhang, H., Wang, Q., Tang, Z., Yuan, J., Lin, H. -S., & Xiang, X. (2021). Investigation of the Impact of CYP3A5 Polymorphism on Drug–Drug Interaction between Tacrolimus and Schisantherin A/Schisandrin A Based on Physiologically-Based Pharmacokinetic Modeling. Pharmaceuticals, 14(3), 198. https://doi.org/10.3390/ph14030198